ethyl nicotinate + methyl salicylate + racemic camphor: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
ethyl nicotinate + methyl salicylate + racemic camphor: clinical details
Prescribing considerations
- General Sales List topical aerosol for symptomatic local relief.
- Confirm the pain is suitable for self-care and reassess persistent symptoms.
- Counsel on inhalation avoidance and aerosol flammability.
- Pregnancy or breastfeeding requires individual consideration because product-specific evidence is limited.
Contraindications and cautions
- Hypersensitivity to any ingredient
- Children under 5 years
- Broken or damaged skin or open cuts
- Application to the eyes, face, mucous membranes or sensitive areas
Monitoring
- No routine laboratory monitoring is specified.
- Assess local irritation or hypersensitivity and review persistent symptoms.
Clinical pharmacology
Methyl salicylate is a locally acting analgesic and counter-irritant; ethyl nicotinate causes superficial vasodilation and rubefaction; camphor provides mild analgesic, rubefacient and counter-irritant activity. Methyl salicylate absorption through the skin varies with formulation and exposure.
Formulation and product differences
- The product is a pressurised topical aerosol containing denatured ethanol and hydrocarbon propellant.
- It is extremely flammable and must be protected from heat and sunlight; the container must not be pierced or burned.
- Massage is not required after application.
ethyl nicotinate + methyl salicylate + racemic camphor interactions
No clinically significant medicine interactions are known. Avoid applying other products to the same area unless a pharmacist or clinician confirms compatibility.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.